DotBio Pte. Ltd. is a biotechnology company that specializes in developing modular, multi‑functional antibody therapeutics—including bi‑specific and tri‑specific antibodies, antibody‑drug conjugates (ADCs), and intracellular antibodies—using its proprietary DotBody platform. It was incorporated in 2017 and is based in Singapore.
Headquarters
45 North Canal Road, #01‑01 Lew Building, Singapore 059301
Singapore; Singapore;
Contact Details: Purchase the DotBio Pte. Ltd. report to view the information.
Website: https://dotbio.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service